1. Home
  2. ELTX vs IKNA Comparison

ELTX vs IKNA Comparison

Compare ELTX & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • IKNA
  • Stock Information
  • Founded
  • ELTX 2011
  • IKNA 2016
  • Country
  • ELTX United States
  • IKNA United States
  • Employees
  • ELTX N/A
  • IKNA N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • IKNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ELTX Health Care
  • IKNA Health Care
  • Exchange
  • ELTX Nasdaq
  • IKNA Nasdaq
  • Market Cap
  • ELTX 49.7M
  • IKNA 83.0M
  • IPO Year
  • ELTX 2021
  • IKNA 2021
  • Fundamental
  • Price
  • ELTX $4.16
  • IKNA $1.68
  • Analyst Decision
  • ELTX Buy
  • IKNA Buy
  • Analyst Count
  • ELTX 2
  • IKNA 2
  • Target Price
  • ELTX $10.00
  • IKNA $3.00
  • AVG Volume (30 Days)
  • ELTX 16.1K
  • IKNA 41.6K
  • Earning Date
  • ELTX 11-07-2024
  • IKNA 11-07-2024
  • Dividend Yield
  • ELTX N/A
  • IKNA N/A
  • EPS Growth
  • ELTX N/A
  • IKNA N/A
  • EPS
  • ELTX N/A
  • IKNA N/A
  • Revenue
  • ELTX N/A
  • IKNA $1,844,000.00
  • Revenue This Year
  • ELTX N/A
  • IKNA N/A
  • Revenue Next Year
  • ELTX N/A
  • IKNA N/A
  • P/E Ratio
  • ELTX N/A
  • IKNA N/A
  • Revenue Growth
  • ELTX N/A
  • IKNA N/A
  • 52 Week Low
  • ELTX $2.96
  • IKNA $1.02
  • 52 Week High
  • ELTX $11.45
  • IKNA $4.63
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 40.82
  • IKNA 51.57
  • Support Level
  • ELTX $4.05
  • IKNA $1.68
  • Resistance Level
  • ELTX $4.89
  • IKNA $1.78
  • Average True Range (ATR)
  • ELTX 0.28
  • IKNA 0.04
  • MACD
  • ELTX -0.06
  • IKNA 0.00
  • Stochastic Oscillator
  • ELTX 27.37
  • IKNA 36.36

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

Share on Social Networks: